Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Belzutifan | Welireg | 4.8. Undesirable effects | Weight increase | May,2024 |
| Fluconazole | Diflucan | 4.6. Fertility, pregnancy and lactation | Fertility and pregnancy | May,2024 |
| Methylphenidate | Concerta | 4.4 Special Warnings and Special Precautions for Use | Risk for abuse, misuse, and addiction | May,2024 |
| Methylphenidate | Concerta | 4.4 Special Warnings and Special Precautions for Use | Risk for abuse, misuse, and addiction | May,2024 |
| Emtricitabine/Tenofovir alafenamide | Descovy | 4.4 Special Warnings and Special Precautions for Use | Nephrotoxicity | May,2024 |
| Naloxone hydrochloride dihydrate/Oxycodone Hydrochloride | Targinact | 4.4 Special Warnings and Special Precautions for Use | Opioid Use Disorder, Biliary tract disorders | May,2024 |